How has been the historical performance of Health.Global?

Answer:The historical performance of Health.Global shows a significant upward trend in net sales and operating profit over the years, with net sales reaching 2,222.85 Cr in March 2025, up from 1,912.12 Cr in March 2024 and 1,694.44 Cr in March 2023. Operating profit also increased to 422.09 Cr in March 2025 from 346.53 Cr in March 2024, indicating improved operational efficiency. However, profit before tax decreased to 56.19 Cr in March 2025 from 67.33 Cr in March 2024, and profit after tax was 48.06 Cr, slightly up from 40.93 Cr in the previous year. The company's total assets rose to 3,518.24 Cr in March 2025, compared to 2,700.44 Cr in March 2024, reflecting growth in both current and non-current assets. Total liabilities also increased to 3,518.24 Cr, with total debt rising to 1,002.23 Cr. Cash flow from operating activities improved to 317.00 Cr in March 2025, although the net cash outflow was -213.00 Cr, indicating challenges in cash management. Breakdown: Health.Global has demonstrated a robust growth trajectory in net sales, which increased from 1,397.79 Cr in March 2022 to 2,222.85 Cr in March 2025. The operating profit margin has remained relatively stable, with a slight increase to 17.46% in March 2025. Despite the rise in sales and operating profit, profit before tax saw a decline in March 2025 compared to the previous year, reflecting increased interest expenses that rose to 154.56 Cr. The company's total assets have significantly increased, indicating a strong growth in both current and non-current assets, while total liabilities also rose, driven by increased borrowings. The cash flow from operating activities has improved, but the overall cash position deteriorated, resulting in a negative closing cash balance in March 2025.